Murat Akarsu

446 total citations
34 papers, 315 citations indexed

About

Murat Akarsu is a scholar working on Immunology, Surgery and Epidemiology. According to data from OpenAlex, Murat Akarsu has authored 34 papers receiving a total of 315 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 8 papers in Surgery and 8 papers in Epidemiology. Recurrent topics in Murat Akarsu's work include COVID-19 Clinical Research Studies (4 papers), Pancreatitis Pathology and Treatment (4 papers) and Inflammation biomarkers and pathways (4 papers). Murat Akarsu is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Pancreatitis Pathology and Treatment (4 papers) and Inflammation biomarkers and pathways (4 papers). Murat Akarsu collaborates with scholars based in Türkiye, United States and Cambodia. Murat Akarsu's co-authors include Tufan Tükek, Yücel Arman, Cevher Akarsu, Samim Emet, Murat Köse, Mustafa Özcan, Timur Selçuk Akpınar, Ömür Tabak, Abdülbaki Kumbasar and Ali Rıza Köksal and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cytokine and Scandinavian Journal of Clinical and Laboratory Investigation.

In The Last Decade

Murat Akarsu

29 papers receiving 298 citations

Peers

Murat Akarsu

IMMUN

SURGE

PHYSI

EPIDE

CCM

Samim Emet Türkiye

Gökhan Aksan Türkiye

Marco Mettimano Italy

Markus Vosseler Germany

Dong Hyung Lee South Korea

Abdelrahman Zamzam Canada

Hadim Akoğlu Türkiye

Fuxue Deng China

Laurent Kohnen Belgium

Samim Emet Türkiye

Murat Akarsu

148 ×1.2

IMMUN

108 ×1.0

SURGE

25 ×0.4

PHYSI

37 ×0.6

EPIDE

104 ×1.8

CCM

Citations per year, relative to Murat Akarsu Murat Akarsu (= 1×) peers Samim Emet

Countries citing papers authored by Murat Akarsu

Since Specialization

Citations

This map shows the geographic impact of Murat Akarsu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murat Akarsu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murat Akarsu more than expected).

Fields of papers citing papers by Murat Akarsu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murat Akarsu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murat Akarsu. The network helps show where Murat Akarsu may publish in the future.

Co-authorship network of co-authors of Murat Akarsu

This figure shows the co-authorship network connecting the top 25 collaborators of Murat Akarsu. A scholar is included among the top collaborators of Murat Akarsu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murat Akarsu. Murat Akarsu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Akarsu, Murat, et al.. (2025). The Relationship of the Plasma Glycated CD59 Level with Microvascular Complications in Diabetic Patients and Its Evaluation as a Predictive Marker. Journal of Clinical Medicine. 14(13). 4588–4588. 1 indexed citations

Akarsu, Murat, et al.. (2025). The Clinical Significance of Serum Sirtuin 2 in Diabetic Nephropathy: Evidence for a Potential Biomarker of Renal Injury. Journal of Clinical Medicine. 14(22). 8095–8095.

Akarsu, Murat, et al.. (2022). Maternal serum preptin levels in the pathogenesis and diagnosis of Gestational diabetes mellitus. Journal of Medical Biochemistry. 42(2). 311–317.

Arman, Yücel, et al.. (2022). O Nível de Endocan Sérico pode ser Usado como Biomarcador para Prever Aterosclerose Subclínica em Pacientes Pré-Diabéticos?. Arquivos Brasileiros de Cardiologia. 119(4). 544–550. 5 indexed citations

Akarsu, Murat, et al.. (2022). Thrombospondin 1 and Nuclear Factor Kappa B Signaling Pathways in Non-alcoholic Fatty Liver Disease. Journal of Gastrointestinal and Liver Diseases. 31(3). 309–316. 5 indexed citations

Bayram, Mehmet, et al.. (2021). Evaluation of hematological indices in terms of COVID-19 related mortality and ICU admission. Journal of Health Sciences and Medicine. 4(5). 666–669. 7 indexed citations

Uzun, Hafize, et al.. (2021). Prognostic nutritional index as indicator of immune nutritional status of patients with COVID-19. International Journal for Vitamin and Nutrition Research. 92(1). 4–12. 11 indexed citations

Arman, Yücel, et al.. (2021). Correlation of glycemic regulation and endotrophin in patients with type 2 Diabetes; pilot study. Diabetology & Metabolic Syndrome. 13(1). 9–9. 9 indexed citations

Akarsu, Murat, et al.. (2021). Is there a correlation between hypomagnesemia linked to long-term proton pump inhibitor use and the active agent?. Wiener klinische Wochenschrift. 134(3-4). 104–109. 3 indexed citations

10.

Bayram, Mehmet, et al.. (2021). Elevation of Serum Transaminase Levels Due to Favipiravir Use in the Treatment of COVID-19. Cureus. 13(9). e18166–e18166. 3 indexed citations

11.

Bayram, Mehmet, et al.. (2021). Prognostic Nutritional Index and Crp, Age, Platelet Count, Albumin Level Score in Predicting Mortality and Intensive Care Unit Admission for Covid-19. Biomarkers in Medicine. 15(18). 1733–1740. 7 indexed citations

12.

Akarsu, Murat, Mehmet Hurşitoğlu, Mustafa Özcan, et al.. (2019). Relationships among oncostatin M, insulin resistance, and chronic inflammation: a pilot study. Archives of Endocrinology and Metabolism. 64(1). 253–253. 7 indexed citations

13.

Hurşitoğlu, Mehmet, Esra Akdenız, Hakan Koçoğlu, et al.. (2019). Early effect of the fear of terrorism on a hospital's emergency department use and on the incidence of cardiovascular events: A Turkish multicenter study. The International Journal of Health Planning and Management. 34(2). 872–879. 2 indexed citations

14.

Atıcı, Adem, et al.. (2019). The role of kidney injury molecule-1 in predicting cardiorenal syndrome type 1 after diuretic treatment. Archives of Medical Science - Atherosclerotic Diseases. 4(1). 208–214. 5 indexed citations

15.

Arman, Yücel, et al.. (2019). Serum Adropin Levels Are Reduced in Adult Patients with Nonalcoholic Fatty Liver Disease. Medical Principles and Practice. 28(5). 463–469. 29 indexed citations

16.

Kartal, Abdülcabbar, et al.. (2019). Colonic Stent Use in Patients With Malignant Flexure Tumors Presenting With Obstruction. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 23(1). e2018.00088–e2018.00088. 5 indexed citations

17.

Arman, Yücel, et al.. (2018). Serum Angiopoietin-like peptide 4 levels in patients with hepatic steatosis. Cytokine. 111. 496–499. 22 indexed citations

18.

Akarsu, Murat, et al.. (2018). Clinical Significance of Diminutive Colonic Polyps in Elderly Patients. JSLS Journal of the Society of Laparoscopic & Robotic Surgeons. 22(4). e2018.00016–e2018.00016. 1 indexed citations

19.

Arman, Yücel, et al.. (2017). COST-EFFECTIVENESS ANALYSIS OF TYPE 2 DIABETES IN OUTPATIENT THERAPY IN TURKEY. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi. 80(3). 92–97.

20.

Atalay, Hasan Anıl, et al.. (2017). Impact of poor glycemic control of type 2 diabetes mellitus on serum prostate-specific antigen concentrations in men. Prostate International. 5(3). 104–109. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact